JNJ: JOHNSON & JOHNSON Profile

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

U.S. Markets open in 5 hrs, 4 mins

Symbol	Value	Change	Percentage Change
DJIA	11,384.21	152.25	1.36%
NASDAQ	2,294.44	51.12	2.28%
S&P 500	1,273.70	21.39	1.71%

JOHNSON & JOHNSON

JNJ

Stock price

66.21 0.96 1.47%

as of 04:01 PM EDT on 07/08/2008 in USD (NYSE Delay: 20 mins.)
Extended Hours

66.21 0.00 0.00%

as of 04:59 PM EDT on 07/08/08

Analyst Consensus

Buy
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: JNJ

Insightful information about industries, companies, and the people who lead them.

Learn More.

2007 Sales	2007 Sales Growth	2007 Net Income	2006 Employees
$61,095,000,000	14.6%	$10,576,000,000	122,200

Key Executives: JNJ

Name	Title	Officer Since
William C. Weldon	CEO	1/1/01
Dominic J. Caruso	CFO	-
Stephen J. Cosgrove	Chief Accounting Officer	-
Russell C. Deyo	General Counsel	-
Sherilyn S. McCoy	Chairman of the Board, Divisional	-
Donald M. Casey, Jr.	Chairman of the Board, Divisional	-
William D. Perez	Director	6/1/07
Colleen A. Goggins	Chairman of the Board, Divisional	-

View All Key Executives

Ms. S. S. McCoy joined the Company in 1982 as an Associate Scientist in Research & Development for Personal Products Company. She was named Vice President, Research & Development for the Personal Products Worldwide Division of McNEIL-PPC, Inc. in 1995, and Vice President, Marketing for its Skin Care franchise in 2000. In 2002, Ms. McCoy became Global President for its Baby and Wound Care franchise. She was named Company Group Chairman and... View Full Profile

Sherilyn S. McCoy

Mr. D. M. Casey, Jr., joined the Company in 1985 and held various positions before becoming President of Johnson & Johnson - Merck Consumer Pharmaceuticals Co. in 1997. In 2001, he was named President of Personal Products Company Division of Johnson & Johnson Consumer Companies, Inc. In 2002, Mr. Casey became the Group President of Johnson & Johnson Vision Care, Inc., and in 2004 was named Company Group Chairman, Vision Care. In November 2006, he... View Full Profile

Donald M. Casey, Jr.

Mr. D. M. Casey, Jr., joined the Company in 1985 and held various positions before becoming President of Johnson & Johnson - Merck Consumer Pharmaceuticals Co. in 1997. In 2001, he was named President of Personal Products Company Division of Johnson & Johnson Consumer Companies, Inc. In 2002, Mr. Casey became the Group President of Johnson & Johnson Vision Care, Inc., and in 2004 was named Company Group Chairman, Vision Care. In November 2006, he... View Full Profile

Stephen J. Cosgrove

Mr. Perez, 60, was appointed to the Board of Directors in June 2007 and is a member of the Compensation & Benefits Committee and the Public Policy Advisory Committee. Mr. Perez has served as President and Chief Executive Officer for the Wm. Wrigley Jr. Company (confectionary and chewing gum) since 2006. Before joining Wrigley, Mr. Perez served as President and Chief Executive Officer of Nike, Inc. Previously, he spent 34 years with S.C. Johnson &... View Full Profile

William D. Perez

Mr. D. J. Caruso joined the Company in 1999 when the Company acquired Centocor, Inc. At the time of that acquisition, he had been Senior Vice President, Finance of Centocor. Mr. Caruso was named Vice President, Finance of Ortho-McNeil Pharmaceutical, Inc. in 2001 and Vice President, Group Finance of the Company's Medical Devices and Diagnostics Group in 2003. In 2005, Mr. Caruso was named Vice President of the Company's Group Finance... View Full Profile

Dominic J. Caruso

Ms. C. A. Goggins joined the Company in 1981 and held various positions before becoming President of Personal Products Company in 1994. She was named President of Johnson & Johnson Consumer Companies, Inc. in 1995 and Company Group Chairman, North America, Johnson & Johnson Consumer Products in 1998. Ms. Goggins became a Member of the Executive Committee and Worldwide Chairman, Consumer & Personal Care Group in 2001, now known as the Consumer... View Full Profile

Colleen A. Goggins

Mr. Prince, 58, was elected to the Board of Directors in 2006 and is a member of the Compensation & Benefits Committee and the Nominating & Corporate Governance Committee. Mr. Prince served as Chief Executive Officer of Citigroup Inc. (financial services) from 2003 to 2007 and as Chairman from 2006 to 2007. Previously he served as Chairman and Chief Executive Officer of Citigroup's Global Corporate and Investment Bank from 2002 to 2003, Chief... View Full Profile

Charles Prince

Dr. Johns, 66, was elected to the Board of Directors in 2005 and is a member of the Compensation & Benefits Committee and the Science & Technology Advisory Committee. He has served since October 2007 as Chancellor of Emory University. From 1996 to 2007, Dr. Johns served as Executive Vice President for Health Affairs and Chief Executive Officer of the Robert W. Woodruff Health Sciences Center of Emory University. As the Executive Vice President... View Full Profile

Dr. Michael M. E. Johns, M.D.

Dr. Satcher, 67, was elected to the Board of Directors in 2002 and is Chairman of the Science & Technology Advisory Committee and a member of the Public Policy Advisory Committee. Dr. Satcher assumed his current post at Morehouse School of Medicine in 2004 and served as the School's Interim President from 2004 until 2006 and Director of the School's National Center for Primary Care from 2002 through 2004. In 2002, Dr. Satcher completed his... View Full Profile

Dr. David Satcher, M.D., Ph.D.

Mr. Cullen, 65, was elected to the Board of Directors in 1995 and is the Presiding Director of the Board, Chairman of the Audit Committee and a member of the Nominating & Corporate Governance Committee. Mr. Cullen retired as President and Chief Operating Officer of Bell Atlantic Corporation (communications) in 2000. He had assumed those positions in 1998, after having been Vice Chairman since 1995 and, prior to that, President since 1993. He was... View Full Profile

James G. Cullen

Mr. Mullin, 65, was elected to the Board of Directors in 1999 and is a member of the Audit Committee and the Chairman of the Public Policy Advisory Committee. Mr. Mullin retired as Chief Executive Officer of Delta Air Lines, Inc. (air transportation) in December 2003 and Chairman in April 2004, after having served as Chief Executive Officer of Delta since 1997 and Chairman since 1999. Mr. Mullin currently serves as a Senior Advisor, on a... View Full Profile

Leo F. Mullin

Dr. Coleman, 64, was elected to the Board of Directors in 2003 and is a member of the Audit Committee and the Science & Technology Advisory Committee. She has served as President of the University of Michigan since August 2002, after having served as President of the University of Iowa from 1995 to July 2002. In addition to her current position as President, Dr. Coleman is a professor of biological chemistry in the University of Michigan Medical... View Full Profile

Dr. Mary Sue Coleman, Ph.D.

Mr. R. C. Deyo joined the Company in 1985 and became Associate General Counsel in 1991. He became a Member of the Executive Committee and Vice President, Administration in 1996 and Vice President, General Counsel in 2004.... View Full Profile

Russell C. Deyo

Mr. Weldon, 59, was elected to the Board of Directors and named Vice Chairman of the Board in 2001 and assumed his current responsibilities in 2002. Mr. Weldon joined the Company in 1971, and served in several sales, marketing and international management positions before becoming President of Ethicon Endo-Surgery in 1992 and Company Group Chairman of Ethicon Endo-Surgery in 1995. He was appointed to the Executive Committee and named Worldwide... View Full Profile

William C. Weldon

Ms. Poon, 55, was elected to the Board of Directors in 2005. Ms. Poon joined the Company in 2000 as a Company Group Chairman in the Pharmaceuticals Group. Ms. Poon became a Member of the Executive Committee and Worldwide Chairman, Pharmaceuticals Group in 2001, was named Worldwide Chairman, Medicines & Nutritionals in 2003 and was appointed Vice Chairman in January 2005. Prior to joining the Company, she served in various management positions at... View Full Profile

Christine A. Poon

Ms. Poon, 55, was elected to the Board of Directors in 2005. Ms. Poon joined the Company in 2000 as a Company Group Chairman in the Pharmaceuticals Group. Ms. Poon became a Member of the Executive Committee and Worldwide Chairman, Pharmaceuticals Group in 2001, was named Worldwide Chairman, Medicines & Nutritionals in 2003 and was appointed Vice Chairman in January 2005. Prior to joining the Company, she served in various management positions at... View Full Profile

Steven S. Reinemund

Mr. Langbo, 70, was elected to the Board of Directors in 1991 and is a member of the Nominating & Corporate Governance Committee and Chairman of the Compensation & Benefits Committee. Mr. Langbo retired as Chairman of Kellogg Company (cereals and convenience foods) in 2000. He had held that position since 1992 after having been President and Chief Operating Officer of Kellogg since 1990. He also served as Chief Executive Officer from 1992 until... View Full Profile

Arnold G. Langbo

Dr. Lindquist, 58, was elected to the Board of Directors in 2004 and is a member of the Science & Technology Advisory Committee and the Public Policy Advisory Committee. Since 2001, Dr. Lindquist has been a member of the Whitehead Institute, a non-profit, independent research and educational institution, a Professor of Biology at the Massachusetts Institute of Technology and an Investigator of the Howard Hughes Medical Institute (HHMI). Dr.... View Full Profile

Dr. Susan L. Lindquist, Ph.D.

Mr. N. J. Valeriani joined the Company in 1978 and held various positions before becoming President of Ethicon Endo-Surgery, Inc. in 1997. In 2001 he was named Company Group Chairman for Ethicon Endo-Surgery with additional responsibility for the Johnson & Johnson Medical Products Medical Devices and Diagnostics business in Canada. He became Worldwide Franchise Chairman for the DePuy Franchise in 2002. Mr. Valeriani became a Member of the... View Full Profile

Nicholas J. Valeriani

Ms. K. I. Foster-Cheek joined the Company in 2003 as Vice President, Human Resources for the Johnson & Johnson consumer products companies. In March 2004, she was named Vice President, Human Resources for the Consumer & Personal Care Group and was named a member of the Human Resources Leadership Team and the Consumer & Personal Care Group Operating Committee. Ms. Foster-Cheek became a Member of the Executive Committee and Vice President, Human... View Full Profile

Kaye I. Foster-Cheek

Top Competitors: JNJ

View Detailed Competitors Chart

Insider Trends: JNJ
Sentiment for JNJ is NEGATIVE
- 0M
- 2M
- 4M
- 6M
- Market Value of Insider Sales
- Market Value of Insider Purchases
Total dollar value of all insider purchases and sales over 12 months
View All Insider Sentiment

Insider Transactions: JNJ

Date	Name	Shares	Transaction Type	Market Value
06/05/08	DEYO RUSSELL C	150	Sale	$10,047.00
05/28/08	SCODARI JOSEPH C	65,085	Planned Sale	$4.21 M
05/28/08	SCODARI JOSEPH C	65,085	Sale	$4.21 M

View All Insider Activity

Ownership Breakdown : JNJ

Large Block Holder Type	Number
Institutions	2,157.00
Mutual Fund	3,983.00
Other Major	23.00

Full Details

Indices : JNJ

Symbol	Name	Last Trade	Change
$RUI.X	Russell 1000 Index	696.61	11.73 1.71%
$INX	S&P 500 Index	1,273.70	21.39 1.71%
$OEX	S&P 100 Index	582.75	8.99 1.57%
$INDU	Dow Jones Industrial Average Index	11,384.21	152.25 1.36%
—	Fortune 500 Industrial Index	—	——%

View all Indices that include JNJ

Short Interest Volume: JNJ

Data as of 6/10/08

Current Short Interest Shares	1.10 B
Current Short Interest Ratio	2.20
Float	2.82 B

Short Interest as % of Float	0.90
Average Daily Volume	11.15 M
Outstanding Shares	2.82 B

Full Details

SEC Filings: JNJ

Accepted Date	Description
07/01/2008	SEC Filing: Insider Buy/Sell
07/01/2008	SEC Filing: Insider Buy/Sell
07/01/2008	SEC Filing: Insider Buy/Sell

View all SEC Filings

Get Profile Details for:

- Help & Feedback

Market Movers

Related Resources

My Portfolios

AOL Real-Time Streaming Quotes

JOHNSON & JOHNSON

JNJ

Stock price

66.21 0.96 1.47%

as of 04:01 PM EDT on 07/08/2008 in USD (NYSE Delay: 20 mins.)
Analyst Consensus
- Strong Buy
- Buy
- Hold
- Sell
- Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: JNJ

Quote Search Search the Web Search

Live Updates:

Ticker

Dynamic view of the market

JOHNSON & JOHNSON

JNJ

Stock price

Extended Hours

Analyst Consensus

JOHNSON & JOHNSON Profile

Key Executives: JNJ

Top Competitors: JNJ

Insider Trends: JNJ

Insider Transactions: JNJ

Ownership Breakdown : JNJ

Indices : JNJ

Short Interest Volume: JNJ

SEC Filings: JNJ

Quote Details

Classic Chart

Advanced Chart BETA

Real-Time Headlines

Message Boards

Profile

Earnings Analysis

Event Calendar

Financials

Market Movers

Related Resources

JOHNSON & JOHNSON

JNJ

Stock price

Analyst Consensus

More in Money & Finance

More Stock Research